Immunoscintigraphy with radiolabeled Cimzia®. ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1

46. Malignant rheumatoid arthritis

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01590966 (ClinicalTrials.gov)	October 18, 2012	30/4/2012	Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNF ...	Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNF ...	Axial and Peripheral Spondyloarthritis;Rheumatoid Arthritis	Drug: administration of Cimzia®;Drug: Immunoscintigraphy with radiolabeled Cimzia®.	University Hospital, Ghent	UCB Pharma SA	Completed	18 Years	70 Years	All	41	Phase 3	Belgium

First Previous1Next Last